CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 62 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $336,000 | -71.5% | 83,607 | -74.0% | 0.03% | -76.7% |
| Q4 2018 | $1,180,000 | -57.2% | 321,430 | 0.0% | 0.13% | -58.0% |
| Q3 2018 | $2,758,000 | -25.2% | 321,430 | -4.3% | 0.32% | -37.7% |
| Q2 2018 | $3,689,000 | -0.5% | 335,987 | +4.5% | 0.51% | -9.6% |
| Q1 2018 | $3,706,000 | +61.6% | 321,430 | +45.2% | 0.56% | +109.3% |
| Q4 2017 | $2,294,000 | -35.0% | 221,430 | 0.0% | 0.27% | -46.6% |
| Q3 2017 | $3,530,000 | +13.2% | 221,430 | -14.1% | 0.50% | -4.9% |
| Q2 2017 | $3,118,000 | -46.2% | 257,665 | -7.7% | 0.53% | -53.2% |
| Q1 2017 | $5,798,000 | +26.6% | 279,166 | -12.8% | 1.13% | -2.2% |
| Q4 2016 | $4,579,000 | -14.4% | 320,229 | -1.5% | 1.16% | +33.1% |
| Q3 2016 | $5,347,000 | +16.8% | 325,053 | 0.0% | 0.87% | -26.7% |
| Q2 2016 | $4,577,000 | +184.6% | 325,053 | +193.0% | 1.19% | +240.4% |
| Q1 2016 | $1,608,000 | – | 110,921 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
| Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
| CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
| BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
| EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
| Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
| Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
| Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
| ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
| Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |